Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schüetz, Beat Müeller, Kristina B Kristoffersen et al.|Cochrane Database of Systematic Reviews|2017Cited by 648
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registryFlorence Tubach, Xavier Mariette|Arthritis & Rheumatism|2009Cited by 631
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysisPhilipp Schüetz, Beat Müeller, Yannick Wirz et al.|The Lancet Infectious Diseases|2017Cited by 473
Neurologic complications and outcomes of infective endocarditis in critically ill patients: The ENDOcardite en REAnimation prospective multicenter study*Romain Sonneville, Michel Wolff, Mariana Mirabel et al.|Critical Care Medicine|2011Cited by 213
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimenÉtienne de Montmollin, Romain Sonneville, Lila Bouadma et al.|Intensive Care Medicine|2014Cited by 112